Pharmacy central in harm minimisation innovation: expert

ecstasy or MDMA stop sign
Pharmacy may have opportunities to help harm minimisation efforts in the future as well as playing a key role in supply of medicinal cannabis, says a drugs expert who presented at last week’s National Drug Summit in Canberra. Dr David Caldicott, an emergency consultant and senior clinical lecturer in Medicine at the Australian National University,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous GPs in the dark without real-time monitoring
Next Hannah Doody is Tasmanian Intern of the Year